^

Metro

FDA recalls anti-TB drug

Mayen Jaymalin - The Philippine Star

MANILA, Philippines - The Food and Drug Administration (FDA) has recalled an anti-tuberculosis drug from the local market.

In an advisory issued yesterday, the FDA said “all consumers are advised not to purchase or use” Picinaf (generic name rifampicin) 450-milligram capsules because laboratory analysis showed them to be below the required potency and would expose patients to a suboptimal dose of the drug.

Picinaf, manufactured by J.M. Tolmann Laboratories Inc. and distributed by Generics Pharmacy, presents a safety risk and possible adverse consequences to consumers.

According to the FDA, rifampicin is used for the treatment of pulmonary and extra-pulmonary tuberculosis.

The FDA ordered distributors, retailers, hospitals, pharmacies and clinics to discontinue the further use or sale of the product.

The agency also ordered its field officers to monitor the availability of the product in the market.

vuukle comment

CONSUMERS

DRUG

DRUG ADMINISTRATION

FDA

GENERICS PHARMACY

MARKET

ORDERED

PICINAF

PRODUCT

TOLMANN LABORATORIES INC

  • Latest
  • Trending
Latest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with